EVOFEM BIOSCIENCES, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $1.3M | $48.9M |
| FY2021 | — | $-104.3M | $7.7M |
| FY2022 | — | $-71.8M | $2.8M |
| FY2023 | — | $-66.5M | $580.0K |
| FY2024 | — | $-71.3M | $741.0K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $1.3M | $48.9M |
| FY2021 | — | $-104.3M | $7.7M |
| FY2022 | — | $-71.8M | $2.8M |
| FY2023 | — | $-66.5M | $580.0K |
| FY2024 | — | $-71.3M | $741.0K |